lobbying_activities: 3338465

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3338465	b13b32b1-17b5-45e6-90c6-4bb0f3a9d96c	Q1	FORBES-TATE	400976792	CSL BEHRING	2025	first_quarter	MED	Issues related to biopharmaceutical pricing; Issues related to plasma and plasma derived therapies; Issues related to the Preserving Life-saving Access to Specialty Medicines in America Act.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2025-04-16T18:59:29-04:00